Target intelligence / Profile preview

Short-chain fatty acid–producing bacterium

Molecular classification
Other
01

Overview

Short-chain fatty acid–producing bacteria are a functional group of gut microbes capable of fermenting dietary fibers and resistant starches to produce short-chain fatty acids (SCFAs), primarily acetate, propionate, and butyrate[1][3]. These bacteria are taxonomically diverse, including genera such as Bacteroides, Prevotella (Bacteroidetes phylum), and various Firmicutes (e.g., Lactobacillaceae, Ruminococcaceae, Lachnospiraceae, Faecalibacterium)[1][3][4][5][6]. SCFAs play key roles in maintaining gut homeostasis, modulating immune function, fueling colonocytes, and influencing systemic metabolism[2][3][6]. A deficiency in SCFA-producing bacteria has been implicated in the pathogenesis of inflammatory bowel disease, metabolic disorders, and some cancers[2][3][6]. While therapies aimed at boosting or modulating SCFA-producing bacteria (using diet, prebiotics, or probiotics) have been proposed, these bacteria themselves are not a single therapeutic target but are considered a functional microbial group or community[2][6]. **Note:** - "Short-chain fatty acid producer bacteria" is not a canonical molecule, protein, gene, or receptor but a collective descriptor for multiple microbial taxa with a shared function, which makes it an incorrect entry as a molecular target[1][2][3][4][5][6].

Other names
SCFA-producing bacteriumSCFA-producing bacteriashort-chain fatty acid producer
02

Biological functions

Gut homeostasisEnergy metabolismImmune modulationInflammatory response regulationCell proliferation in colonic epithelium
03

Disease associations

InflammationAutoimmune diseasesMetabolic disorderInflammatory bowel diseaseObesityType 2 diabetesColorectal cancerCardiometabolic disease
04

Safety considerations

Manipulation of global gut microbiota may result in unpredictable changes in metabolite production, including potentially harmful by-productsOvergrowth of certain bacterial taxa could disrupt microbiome balance, potentially leading to dysbiosis
05

Biomarkers

Levels or composition of short-chain fatty acid–producing bacteria in feces or gut microbiome samples (proxy SCFA profiling)

Beyond the preview

Go deeper on Short-chain fatty acid–producing bacterium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Short-chain fatty acid–producing bacterium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call